Cost-Effectiveness Analyses of Salmeterol/Fluticasone Propionate Combination Product and Fluticasone Propionate in Patients with Asthma I: Introduction and Overview
| Autor: | Gunnar Johansson, Seema Sondhi, Robert M.A. Thwaites, Bo Lundbäck, Willem R. Pieters, Martin J. Price, Mona Palmqvist |
|---|---|
| Rok vydání: | 1999 |
| Předmět: |
Pharmacology
medicine.medical_specialty Health economics Cost effectiveness business.industry Health Policy Public Health Environmental and Occupational Health medicine.disease Fluticasone propionate Health administration Pharmacotherapy Combination Product medicine Salmeterol Intensive care medicine business medicine.drug Asthma |
| Zdroj: | PharmacoEconomics. 16:1-8 |
| ISSN: | 1179-2027 1170-7690 |
| DOI: | 10.2165/00019053-199916002-00001 |
| Popis: | When a new drug therapy is introduced, it is important to consider the economic impact of the treatment. This is particularly relevant for a chronic disease such as asthma. Despite an increased understanding of the physiology of asthma, this condition remains an important cause of morbidity and mortality in many countries and places a large financial burden on healthcare systems. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink